Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calcium folinate 12.5mg/5ml oral liquid
0801000I0AAAYAY
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 15mg/2ml solution for injection ampoules
0801000I0AAAGAG
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 200mg/20ml solution for injection vials
0801000I0AABHBH
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 300mg/30ml solution for injection vials
0801000I0AAAPAP
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 30mg/10ml solution for injection ampoules
0801000I0AAAFAF
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 33.333mg/5ml oral liquid
0801000I0AABCBC
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 350mg/35ml solution for injection vials
0801000I0AABEBE
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 37.5mg/5ml oral liquid
0801000I0AAAZAZ
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 3mg/1ml solution for injection ampoules
0801000I0AAAAAA
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 500mg/50ml solution for infusion vials
0801000I0AABIBI
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 50mg/5ml solution for injection ampoules
0801000I0AABGBG
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 50mg/5ml solution for injection vials
0801000I0AAAMAM
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 6.67mg/5ml oral liquid
0801000I0AABBBB
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium folinate 7.5mg/5ml oral liquid
0801000I0AAAXAX
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium levofolinate 175mg/17.5ml inj vials
0801000U0AAABAB
|
Calcium levofolinate | Calcium levofolinate | Malignant Disease and Immunosuppression | No data available |
|
Calcium levofolinate 25mg/2.5ml solution for injection vials
0801000U0AAAAAA
|
Calcium levofolinate | Calcium levofolinate | Malignant Disease and Immunosuppression | No data available |
|
Campto 100mg/5ml concentrate for solution for infusion vials
0801050Q0BBAAAA
|
Campto | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Campto 300mg/15ml concentrate for inf vials
0801050Q0BBACAC
|
Campto | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Campto 40mg/2ml concentrate for solution for infusion vials
0801050Q0BBABAB
|
Campto | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Canakinumab 150mg powder for solution for injection vials
0802040ACAAAAAA
|
Canakinumab | Canakinumab | Malignant Disease and Immunosuppression | No data available |
|
Canakinumab 150mg/1ml inj pre-filled disposable devices
0802040ACAAACAC
|
Canakinumab | Canakinumab | Malignant Disease and Immunosuppression | No data available |
|
Canakinumab 150mg/1ml solution for injection vials
0802040ACAAABAB
|
Canakinumab | Canakinumab | Malignant Disease and Immunosuppression | No data available |
|
Capecitabine 300mg tablets
0801030V0AAACAC
|
Capecitabine | Capecitabine | Malignant Disease and Immunosuppression | No data available |
|
Capecitabine 500mg tablets
0801030V0AAAAAA
|
Capecitabine | Capecitabine | Malignant Disease and Immunosuppression | No data available |
|
Capexion 0.5mg capsules
0802020T0BHAAAF
|
Capexion | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.